1Jemal A, Siegel R, Ward E,et al. Cancer statistics, 2009[J]. CA Cancer J Clin, 2009, 59 (4) : 225 - 249.
2Crist DW, Sitzmann JV, Cameron JL. Improved hospital morbidity, mortality, and survival after the Whipple procedure[ J]. Ann Surg, 1987, 206 (3) : 358 - 365.
3Li D, Xie K, Wolff R, et al. Pancreatic cancer [ J]. Lancet, 2004, 363:1049 - 1057.
4Bipat S, Phoa SS, van Delden OM, et al. Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta - analysis[ J ]. J Comput Assist Tomogr, 2005, 29 (4) : 438 - 445.
5National Comprehensive Cancer Network (NCCN) Clinical Practice Guideline in Oncology for Pancreatic Adenocarcinoma V [ S ]. 1. 2009.
8Katz MH, Pisters PW, Evans DB, et al. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease[ J]. J Am Coll Surg, 2008, 206 (5) : 833 - 846.
9Evans DB, Varadhachary GR, Crane CH, et al. Preoperative gemcitabine- based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head[ J]. J Clin Oncol, 2008,26: 3496 - 3502,.
10Gillen S, Schuster T, Meyer ZC, et al. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta- analysis of response and resection percentages[ J]. PLoS Med, 2010, 7 (4): e1000267.
二级参考文献40
1Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008 [J]. CA Cancer J Clin, 2008, 58(2) : 71-96.
2Cameron JL, Riall TS, Coleman J, etal. One thousand consecutive pancreaticoduodenectomies [J]. Ann Surg, 2006, 244(1): 10-15.
3Richter A, Niedergethmann M, Sturm JW, etal. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head.. 25 year experience [J]. World J Surg, 2003, 27(3): 324-329.
4Carpelan-Holmstrom M, Nordling S, Pukkala E, et al. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry [J]. Gut, 2005,54(3): 385-387.
5Winter JM, Cameron JL, Campbell KA, et al. 1 423 pancreaticoduodenectomies for pancreatic cancer: A single institution experience [J]. J Gastrointest Surg, 2006, 10 (9) : 1199-1211.
6Loos M, Kleeff J, Friess H, etal. Surgical treatment of pancreatic cancer [J]. Ann N Y Aead Sci, 2008, 1138: 169- 180.
7Sener SF, Fremgen A, Menck HR, et al. Pancreatic cancer: a report of treatment and survival trends for 100-313 patients diagnosed from 1985-1995, using the National Cancer Database[J]. J Am CollSurg, 1999, 189(1): 1-7.
8Katz MH, Hwang R, Fleming JB, et al. Tumor-node-metastasis staging of pancreatic adenocarcinoma [J]. CA Cancer J Clin, 2008,58(2):111- 125.
9National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oneology for Pancreatic Adenocarcinoma. http://www, nccn. org/professionals/physican_gls/default, asp. Accessed February 6, 2008.
10Varadhachary GR, Tamm EP, Ahbruzzese JL, et al. Borderline reseetable pancreatic cancer: definitions, management, and role of preoperative therapy [J]. Ann Surg Oncol, 2006 , 13(8) : 1035-1046.
